Latest News
A health ministry panel in Japan has approved the testing of human-induced pluripotent stem cells to treat spinal cord injuries.
Alzheimer’s Research UK are funding a clinical trial to investigate the use of Sativex®, a cannabis-based medicine for the treatment of behavioral changes experienced as a result of dementia.
Night owls and morning larks have been reported to have fundamental differences in their brain function, according to a new study.
Journal Articles
In this review from Biomarkers in Medicine, researchers demonstrate that PARK7 and NDKA could present more clinical important information as biomarkers for management of stroke disease.
Take a look behind the scenes of a recent CNS Oncology paper as we ask the authors about the Nativis Voyager® for the treatment of glioblastoma.
In this review article from Biomarkers in Medicine, researchers explore the current application of blood-based markers to assess amyloid-β pathology.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Role of PARK7 and NDKA in stroke management: a review of PARK7 and NDKA as stroke biomarkers
CNS/PNS/SNS
3D printed scaffold promotes nerve cell growth for spinal cord injury
Advances in enteric neurobiology – the ‘brain’ in the gut in health and disease
SfN18: Advances in brain–computer interfaces may improve therapies and prosthetics
Cognitive/neurodegenerative disorders
Could cannabis-based medicines be used to combat the symptoms of dementia?
Blood biomarkers for neurological disease research: current status, challenge and future outlook
Dementia risk factors unidentifiable in half of adults surveyed
Demyelinating disease
Multiple sclerosis: determining the dynamic nature of oligodendrocyte regeneration
Biomarker discovery and development in multiple sclerosis: where are we now?
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Development and pediatrics
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Gilenya® gains EMA approval for pediatric multiple sclerosis
Artificial intelligence and home videos: a new diagnostic method for autism?
Epilepsy and seizure
Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
Cannabidiol for epilepsy expected to be available within 6 weeks: industry news round-up
Genetics
SfN18: The potential of gene therapy in neurological disorders
Treasure trove of 102 genes associated with autism identified
Monogenic neurodevelopmental disorders may not be as simple as they seem
Headache
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Alzheimer’s drug development halted following toxic reaction: industry news round-up
Aimovig® receives EMA license for the prevention of migraine
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
Link between Alzheimer’s disease and periodontal bacteria gains traction
Injury/trauma
World’s first iPS trial approved in Japan for spinal cord injuries
‘Punch drunk syndrome’: an early career perspective with Marc Goldfinger
‘Punch drunk syndrome’: an introduction to CTE, clinical relevance and pathology
Movement disorders
Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
RESTORE-1: first patient dosed with gene therapy in Parkinson’s trial
BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis
Neuro-ophthalmology
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Glaucoma research gives a glimpse of a novel neuroprotection mechanism
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Risk of depression linked to cannabis use in teens
Treasure trove of 269 genes associated with depression identified
Oncology/tumor
SurVaxM for newly diagnosed glioblastoma: an interview with Manmeet Ahluwalia
Recurrent glioblastoma could be effectively treated using pembrolizumab
A peek behind the paper – Charles Cobbs on the Nativis Voyager® for the treatment of glioblastoma
Pain
Could neuropathic pain be treated by modulation of immune cells?
New smartphone application could detect first signs of opioid overdose
The opioid epidemic: could a vaccine prevent addiction and overdose?
Sleep
Night owls vs morning larks: are there differences in brain function?
SfN18: Disrupted sleep may exacerbate anxiety and brain disorders
